Latest filing published 10 Aug 2026 for BlossomHill Therapeutics, Inc., €34k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Vincent Paul Liptak: trading record in brief
This profile gathers the share dealings of Vincent Paul Liptak in BlossomHill Therapeutics, Inc. Over a trading history stretching from 7 August 2026 to 10 August 2026, the count stands at 3 filings.
No open-market sale appears; the market trades are 2 purchases worth €65k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 10 August 2026: a transaction, in BlossomHill Therapeutics, Inc. The clock since the last published purchase (10 August 2026) now reads 90 days. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Vincent Paul Liptak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$15.80Common StockSEC:0002143905-26-000003:0Canonical exit: 5 Nov 2026 (T+90)
- 2,200 shares@ US$16.00Common StockSEC:0002143905-26-000003:1Canonical exit: 8 Nov 2026 (T+90)
- 22,687 sharesCommon StockSEC:0002143905-26-000003:2
3 of 3 declarations
